跳至主要内容
临床试验/NCT04679207
NCT04679207已完成不适用

A Pilot Study of Ultrasound-guided Vacuum-assisted Excision of Breast Cancers (the PICASSO Study)

Manchester University NHS Foundation Trust1 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2018年6月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
7
试验地点
1
主要终点
Greatest dimension of the Cancer

研究概览

简要总结

This study is looking into whether the procedure called Vacuum Assisted Excision (VAE) is a safe method for the removal of small and medium sized invasive breast cancers in patients who are unfit or have refused to have surgery to remove cancer.

Recruitment Target: 20

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • The patient is aged 18 years or older.
  • Diagnosis on core needle biopsy of invasive cancer of the breast
  • Unifocal invasive tumour on imaging (hormone receptor positive or negative)
  • T1 or T2 primary or locally recurrent tumour measuring ≤25mm on imaging, excluding any adjacent ductal carcinoma in situ (largest of the measurements on mammography (including digital breast tomosynthesis if performed) and ultrasound)
  • The tumour is clearly visible on ultrasound
  • Vacuum-assisted excision of the entire ultrasonically visible tumour is deemed to be technically feasible
  • The patient is considered to be at high risk of complications or death from a general anaesthetic and therefore surgery under general anaesthesia is not considered appropriate. This must be confirmed by agreement by two named consultant breast surgeons, a multidisciplinary team meeting (including at least one consultant breast surgeon) or by formal anaesthetic assessment. Unsuitability for surgery under local anaesthetic must be confirmed by a consultant breast surgeon.
  • or - The patient refuses to undergo surgery. This must be confirmed by a consultant surgeon and breast care nurse following full discussion of the treatment options.
  • or - The patient is considered unlikely to benefit from surgical removal of the cancer by virtue of known metastatic disease or other life-shortening condition. This must be confirmed by discussion in a multidisciplinary team meeting which includes an oncologist.
  • The patient has given written informed consent for the study Women who are already on primary endocrine therapy for a breast cancer and meet the inclusion criteria will also be eligible.

排除标准

  • The patient is on anticoagulants or has a known clotting disorder
  • Pregnancy or lactation
  • Allergy to local anaesthetic

结局指标

主要结局

Greatest dimension of the Cancer

时间窗: 1 year

The proportion of participants in whom the greatest dimension of the cancer on imaging at 1 year post-vacuum assisted excision (VAE) is ≤50% of its pre-VAE size.

次要结局

  • Complication rate of VAE(12 months)
  • Recruitment Uptake(12 months)
  • Procedure Times(12 months)
  • Proportion of Cancer removed(12 months)
  • Procedure pain and acceptability(12 months)
  • proportion willing to undergo the procedure again if necessary.(12 months)
  • Requirement of salvage surgery(2 years post VAE)
  • Residual Cancer after VAE(2 years post VAE)
  • Histopathology of cavity walls(Imaging at 1 year and 2 years.)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验